We assessed the gut microbiota of 90 American young adults, comparing 43 participants
with major depressive disorder (MDD) and 47 healthy controls, and found that the MDD …

Major depressive disorder (MDD) is a common severe psychiatric illness, exhibiting sub-
optimal response to existing pharmacological treatments. Although its etiopathogenesis is …

Background: A growing body of research has shown that consumption of probiotics can
improve symptoms associated with mood and anxiety disorders through activity of the gut …

The review summarizes the existent literature on this emerging research field and provides a
comprehensive overview of the multifaceted links between the microbiota, diet, and …

Major depressive disorder (MDD) is a psychiatric condition that affects a large number of
people in the world, and the treatment existents do not work for all individuals affected. Thus …

Depression is one of the most common psychiatric conditions, characterized by significant
and persistent depressed mood and diminished interest, and often coexists with various …

The emergence of the coronavirus disease 2019 pandemic has dramatically increased the
global prevalence of depression. Unfortunately, antidepressant drugs benefit only a small …

With growing interest in the gut microbiome, prebiotics and probiotics have received
considerable attention as potential treatments for depression and anxiety. We conducted a …

The gut microbiome is thought to play a role in depressive disorders, which makes it an
attractive target for interventions. Both the microbiome and depressive symptom levels vary …

Background: There is a crucial link between the gut microbiota and the host central nervous
system, and the communication between them occurs via a bidirectional pathway termed the …